Press Room

Find news and updates from PhRMA, representing the country’s leading biopharmaceutical research companies. Our members are committed to finding tomorrow’s cures and treatments for some of the most serious diseases such as cancer, Alzheimer’s disease, cystic fibrosis and Parkinson’s.

Latest News from PhRMA

Fighting multiple sclerosis: New Together ad illuminates the journey of patient & scientist

May 31, 2017

This blog post highlights the launch of a new GOBOLDLY advertisement in the Together ad series on multiple sclerosis.

Read More

Medicare Monday: Catch up on MedPAC and its Part B recommendations

May 29, 2017

Reading list on the Medicare Payment Advisory Commission.

Read More

Medicines have significantly increased chances of cancer survival around the globe

May 24, 2017

Since a peak in 1991, cancer mortality rates have declined by

Read More

PhRMA Statement on Intellectual Property Enforcement Coordinator

May 24, 2017

PhRMA released the following statement on the appointment of Vishal Amin as Intellectual Property Enforcement Coordinator.

Read More

Administration’s Special 301 Report highlights deteriorating global environment for biopharmaceutical innovation

May 23, 2017

In the latest publication of its annual Special 301 Report, the Office

Read More

Medicare Monday: Did you know Medicare Part B uses a market-based system to pay for medicines?

May 22, 2017

A closer look at the market-based changes that the MMA made to Medicare Part B with the creation of Average Sales Price (ASP).

Read More

Compulsory licensing: A misused and abused international trade law

May 16, 2017

To maintain our position as the world’s top biopharmaceutical

Read More

Medicare Monday: Why imposing Medicaid-style rebates in Part D is a bad idea

May 15, 2017

Why imposing Medicaid-style rebates in Medicare Part D is a bad idea.

Read More

A New World of Medicine: New GOBOLDLY ads showcase groundbreaking scientific advancements

May 15, 2017

New World ad features some of the most extraordinary breakthroughs in science being discovered by biopharmaceutical researchers.

Read More

ICYMI: New study shows medicines advance life expectancy for HIV patients

May 15, 2017

The biopharmaceutical industry has worked rigorously to improve medicines for treating HIV/AIDS

Read More